Global Blood Screening Market Overview:
Global Blood Screening Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Blood Screening Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Blood Screening involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Blood Screening Market:
The Blood Screening Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Blood Screening Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Blood Screening Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Blood Screening market has been segmented into:
Reagents and Instruments
By Application, Blood Screening market has been segmented into:
Nucleic Acid Amplification Test (NAT
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Blood Screening market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Blood Screening market.
Top Key Players Covered in Blood Screening market are:
F. Hoffmann-La Roche Ltd.
Grifols
bioMérieux
Bio-Rad Laboratories
Inc.
Danaher Corporation
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Blood Screening Market Type
4.1 Blood Screening Market Snapshot and Growth Engine
4.2 Blood Screening Market Overview
4.3 Reagents and Instruments
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Reagents and Instruments: Geographic Segmentation Analysis
Chapter 5: Blood Screening Market Application
5.1 Blood Screening Market Snapshot and Growth Engine
5.2 Blood Screening Market Overview
5.3 Nucleic Acid Amplification Test (NAT
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Nucleic Acid Amplification Test (NAT: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Blood Screening Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 F. HOFFMANN-LA ROCHE LTD.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 GRIFOLS
6.4 BIOMÉRIEUX
6.5 BIO-RAD LABORATORIES
6.6 INC.
6.7 DANAHER CORPORATION
Chapter 7: Global Blood Screening Market By Region
7.1 Overview
7.2. North America Blood Screening Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Reagents and Instruments
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Nucleic Acid Amplification Test (NAT
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Blood Screening Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Reagents and Instruments
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Nucleic Acid Amplification Test (NAT
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Blood Screening Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Reagents and Instruments
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Nucleic Acid Amplification Test (NAT
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Blood Screening Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Reagents and Instruments
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Nucleic Acid Amplification Test (NAT
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Blood Screening Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Reagents and Instruments
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Nucleic Acid Amplification Test (NAT
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Blood Screening Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Reagents and Instruments
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Nucleic Acid Amplification Test (NAT
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Blood Screening Scope:
|
Report Data
|
Blood Screening Market
|
|
Blood Screening Market Size in 2025
|
USD XX million
|
|
Blood Screening CAGR 2025 - 2032
|
XX%
|
|
Blood Screening Base Year
|
2024
|
|
Blood Screening Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
F. Hoffmann-La Roche Ltd., Grifols, bioMérieux, Bio-Rad Laboratories, Inc., Danaher Corporation.
|
|
Key Segments
|
By Type
Reagents and Instruments
By Applications
Nucleic Acid Amplification Test (NAT
|
